【調査レポート】グルテチミドのグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Glutethimide Market Insights, Forecast to 2028

QYResearchが調査・発行した産業分析レポートです。グルテチミドのグローバル市場インサイト・予測（～2028年） / Global Glutethimide Market Insights, Forecast to 2028 / QY2207C3464資料のイメージです。

• レポートコード：QY2207C3464
• 出版社/出版日：QYResearch / 2022年7月11日
• レポート形態：英文、PDF、114ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥725,200 (USD4,900)	▷ お問い合わせ
Multi User	￥1,087,800 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,450,400 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

新型コロナウイルス感染症のパンデミックにより、世界のグルテチミドの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にグルテチミドの世界市場のxxx％を占める「錠剤」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院薬局」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
中国のグルテチミドの市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのグルテチミド市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのグルテチミド市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

グルテチミドのグローバル主要メーカーには、Pfizer、Abbott Laboratories、Mankind Pharma、Glaxosimithkine、Sanofi、Novartis、Abbvie、Bristol Mayers Squibb、Astrazeneca、Agilent Technologiesなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

グルテチミド市場は、種類と用途によって区分されます。世界のグルテチミド市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
錠剤、注射、カプセル

【用途別セグメント】
病院薬局、小売薬局、オンライン薬局

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- グルテチミド製品概要
- 種類別市場（錠剤、注射、カプセル）
- 用途別市場（病院薬局、小売薬局、オンライン薬局）
- 調査の目的
・エグゼクティブサマリー
- 世界のグルテチミド販売量予測2017-2028
- 世界のグルテチミド売上予測2017-2028
- グルテチミドの地域別販売量
- グルテチミドの地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別グルテチミド販売量
- 主要メーカー別グルテチミド売上
- 主要メーカー別グルテチミド価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（錠剤、注射、カプセル）
- グルテチミドの種類別販売量
- グルテチミドの種類別売上
- グルテチミドの種類別価格
・用途別市場規模（病院薬局、小売薬局、オンライン薬局）
- グルテチミドの用途別販売量
- グルテチミドの用途別売上
- グルテチミドの用途別価格
・北米市場
- 北米のグルテチミド市場規模（種類別、用途別）
- 主要国別のグルテチミド市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパのグルテチミド市場規模（種類別、用途別）
- 主要国別のグルテチミド市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋のグルテチミド市場規模（種類別、用途別）
- 主要国別のグルテチミド市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米のグルテチミド市場規模（種類別、用途別）
- 主要国別のグルテチミド市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカのグルテチミド市場規模（種類別、用途別）
- 主要国別のグルテチミド市場規模（トルコ、サウジアラビア）
・企業情報
Pfizer、Abbott Laboratories、Mankind Pharma、Glaxosimithkine、Sanofi、Novartis、Abbvie、Bristol Mayers Squibb、Astrazeneca、Agilent Technologies
・産業チェーン及び販売チャネル分析
- グルテチミドの産業チェーン分析
- グルテチミドの原材料
- グルテチミドの生産プロセス
- グルテチミドの販売及びマーケティング
- グルテチミドの主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- グルテチミドの産業動向
- グルテチミドのマーケットドライバー
- グルテチミドの課題
- グルテチミドの阻害要因
・主な調査結果

Glutethimide is a hypnotic sedative drug which is a safe alternative to barbiturates for treatment of insomnia. It mainly used for patients to feel sleepy and make them calm. Glutethimide is highly lipophilic and concentrates in adipose tissue and brain. It is an alternative for barbiturates. It undergoes extensive metabolism in liver with both unconjugated and conjugated metabolites which kidney excretes. Glutethimide is a CYP2D6 enzyme inducer and when it taken with codeine, it enables the body to convert high amount of codeine to morphine. The most common brand name for glutethimide are ciba, glue, and gofers. It is categorized as schedule II drug under psychotropic substances. Moreover, glutethimide is used to prevent jaundice in newborns and reduce muscle tremors.
Market Analysis and Insights: Global Glutethimide Market
The global Glutethimide market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Tablets accounting for % of the Glutethimide global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital Pharmacy segment is altered to an % CAGR throughout this forecast period.
China Glutethimide market size is valued at US$ million in 2021, while the North America and Europe Glutethimide are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Glutethimide landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Glutethimide market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Glutethimide market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Glutethimide market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Glutethimide market.
Global Glutethimide Scope and Market Size
Glutethimide market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Glutethimide market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Tablets
Injection
Capsules
Segment by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
By Company
Pfizer
Abbott Laboratories
Mankind Pharma
Glaxosimithkine
Sanofi
Novartis
Abbvie
Bristol Mayers Squibb
Astrazeneca
Agilent Technologies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

レポート目次

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Glutethimide Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Tablets
1.2.3 Injection
1.2.4 Capsules
1.3 Market by Application
1.3.1 Global Glutethimide Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Glutethimide Market Perspective (2017-2028)
2.2 Glutethimide Growth Trends by Region
2.2.1 Glutethimide Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Glutethimide Historic Market Size by Region (2017-2022)
2.2.3 Glutethimide Forecasted Market Size by Region (2023-2028)
2.3 Glutethimide Market Dynamics
2.3.1 Glutethimide Industry Trends
2.3.2 Glutethimide Market Drivers
2.3.3 Glutethimide Market Challenges
2.3.4 Glutethimide Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Glutethimide Players by Revenue
3.1.1 Global Top Glutethimide Players by Revenue (2017-2022)
3.1.2 Global Glutethimide Revenue Market Share by Players (2017-2022)
3.2 Global Glutethimide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Glutethimide Revenue
3.4 Global Glutethimide Market Concentration Ratio
3.4.1 Global Glutethimide Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Glutethimide Revenue in 2021
3.5 Glutethimide Key Players Head office and Area Served
3.6 Key Players Glutethimide Product Solution and Service
3.7 Date of Enter into Glutethimide Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Glutethimide Breakdown Data by Type
4.1 Global Glutethimide Historic Market Size by Type (2017-2022)
4.2 Global Glutethimide Forecasted Market Size by Type (2023-2028)
5 Glutethimide Breakdown Data by Application
5.1 Global Glutethimide Historic Market Size by Application (2017-2022)
5.2 Global Glutethimide Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Glutethimide Market Size (2017-2028)
6.2 North America Glutethimide Market Size by Type
6.2.1 North America Glutethimide Market Size by Type (2017-2022)
6.2.2 North America Glutethimide Market Size by Type (2023-2028)
6.2.3 North America Glutethimide Market Share by Type (2017-2028)
6.3 North America Glutethimide Market Size by Application
6.3.1 North America Glutethimide Market Size by Application (2017-2022)
6.3.2 North America Glutethimide Market Size by Application (2023-2028)
6.3.3 North America Glutethimide Market Share by Application (2017-2028)
6.4 North America Glutethimide Market Size by Country
6.4.1 North America Glutethimide Market Size by Country (2017-2022)
6.4.2 North America Glutethimide Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Glutethimide Market Size (2017-2028)
7.2 Europe Glutethimide Market Size by Type
7.2.1 Europe Glutethimide Market Size by Type (2017-2022)
7.2.2 Europe Glutethimide Market Size by Type (2023-2028)
7.2.3 Europe Glutethimide Market Share by Type (2017-2028)
7.3 Europe Glutethimide Market Size by Application
7.3.1 Europe Glutethimide Market Size by Application (2017-2022)
7.3.2 Europe Glutethimide Market Size by Application (2023-2028)
7.3.3 Europe Glutethimide Market Share by Application (2017-2028)
7.4 Europe Glutethimide Market Size by Country
7.4.1 Europe Glutethimide Market Size by Country (2017-2022)
7.4.2 Europe Glutethimide Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Glutethimide Market Size (2017-2028)
8.2 Asia-Pacific Glutethimide Market Size by Type
8.2.1 Asia-Pacific Glutethimide Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Glutethimide Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Glutethimide Market Share by Type (2017-2028)
8.3 Asia-Pacific Glutethimide Market Size by Application
8.3.1 Asia-Pacific Glutethimide Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Glutethimide Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Glutethimide Market Share by Application (2017-2028)
8.4 Asia-Pacific Glutethimide Market Size by Region
8.4.1 Asia-Pacific Glutethimide Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Glutethimide Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Glutethimide Market Size (2017-2028)
9.2 Latin America Glutethimide Market Size by Type
9.2.1 Latin America Glutethimide Market Size by Type (2017-2022)
9.2.2 Latin America Glutethimide Market Size by Type (2023-2028)
9.2.3 Latin America Glutethimide Market Share by Type (2017-2028)
9.3 Latin America Glutethimide Market Size by Application
9.3.1 Latin America Glutethimide Market Size by Application (2017-2022)
9.3.2 Latin America Glutethimide Market Size by Application (2023-2028)
9.3.3 Latin America Glutethimide Market Share by Application (2017-2028)
9.4 Latin America Glutethimide Market Size by Country
9.4.1 Latin America Glutethimide Market Size by Country (2017-2022)
9.4.2 Latin America Glutethimide Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Glutethimide Market Size (2017-2028)
10.2 Middle East & Africa Glutethimide Market Size by Type
10.2.1 Middle East & Africa Glutethimide Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Glutethimide Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Glutethimide Market Share by Type (2017-2028)
10.3 Middle East & Africa Glutethimide Market Size by Application
10.3.1 Middle East & Africa Glutethimide Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Glutethimide Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Glutethimide Market Share by Application (2017-2028)
10.4 Middle East & Africa Glutethimide Market Size by Country
10.4.1 Middle East & Africa Glutethimide Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Glutethimide Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Glutethimide Introduction
11.1.4 Pfizer Revenue in Glutethimide Business (2017-2022)
11.1.5 Pfizer Recent Developments
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Details
11.2.2 Abbott Laboratories Business Overview
11.2.3 Abbott Laboratories Glutethimide Introduction
11.2.4 Abbott Laboratories Revenue in Glutethimide Business (2017-2022)
11.2.5 Abbott Laboratories Recent Developments
11.3 Mankind Pharma
11.3.1 Mankind Pharma Company Details
11.3.2 Mankind Pharma Business Overview
11.3.3 Mankind Pharma Glutethimide Introduction
11.3.4 Mankind Pharma Revenue in Glutethimide Business (2017-2022)
11.3.5 Mankind Pharma Recent Developments
11.4 Glaxosimithkine
11.4.1 Glaxosimithkine Company Details
11.4.2 Glaxosimithkine Business Overview
11.4.3 Glaxosimithkine Glutethimide Introduction
11.4.4 Glaxosimithkine Revenue in Glutethimide Business (2017-2022)
11.4.5 Glaxosimithkine Recent Developments
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Glutethimide Introduction
11.5.4 Sanofi Revenue in Glutethimide Business (2017-2022)
11.5.5 Sanofi Recent Developments
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Glutethimide Introduction
11.6.4 Novartis Revenue in Glutethimide Business (2017-2022)
11.6.5 Novartis Recent Developments
11.7 Abbvie
11.7.1 Abbvie Company Details
11.7.2 Abbvie Business Overview
11.7.3 Abbvie Glutethimide Introduction
11.7.4 Abbvie Revenue in Glutethimide Business (2017-2022)
11.7.5 Abbvie Recent Developments
11.8 Bristol Mayers Squibb
11.8.1 Bristol Mayers Squibb Company Details
11.8.2 Bristol Mayers Squibb Business Overview
11.8.3 Bristol Mayers Squibb Glutethimide Introduction
11.8.4 Bristol Mayers Squibb Revenue in Glutethimide Business (2017-2022)
11.8.5 Bristol Mayers Squibb Recent Developments
11.9 Astrazeneca
11.9.1 Astrazeneca Company Details
11.9.2 Astrazeneca Business Overview
11.9.3 Astrazeneca Glutethimide Introduction
11.9.4 Astrazeneca Revenue in Glutethimide Business (2017-2022)
11.9.5 Astrazeneca Recent Developments
11.10 Agilent Technologies
11.10.1 Agilent Technologies Company Details
11.10.2 Agilent Technologies Business Overview
11.10.3 Agilent Technologies Glutethimide Introduction
11.10.4 Agilent Technologies Revenue in Glutethimide Business (2017-2022)
11.10.5 Agilent Technologies Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Glutethimide Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Tablets
Table 3. Key Players of Injection
Table 4. Key Players of Capsules
Table 5. Global Glutethimide Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 6. Global Glutethimide Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Glutethimide Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Glutethimide Market Share by Region (2017-2022)
Table 9. Global Glutethimide Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Glutethimide Market Share by Region (2023-2028)
Table 11. Glutethimide Market Trends
Table 12. Glutethimide Market Drivers
Table 13. Glutethimide Market Challenges
Table 14. Glutethimide Market Restraints
Table 15. Global Glutethimide Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Glutethimide Revenue Share by Players (2017-2022)
Table 17. Global Top Glutethimide by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Glutethimide as of 2021)
Table 18. Ranking of Global Top Glutethimide Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Glutethimide Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Glutethimide Product Solution and Service
Table 22. Date of Enter into Glutethimide Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Glutethimide Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Glutethimide Revenue Market Share by Type (2017-2022)
Table 26. Global Glutethimide Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Glutethimide Revenue Market Share by Type (2023-2028)
Table 28. Global Glutethimide Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Glutethimide Revenue Share by Application (2017-2022)
Table 30. Global Glutethimide Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Glutethimide Revenue Share by Application (2023-2028)
Table 32. North America Glutethimide Market Size by Type (2017-2022) & (US$ Million)
Table 33. North America Glutethimide Market Size by Type (2023-2028) & (US$ Million)
Table 34. North America Glutethimide Market Size by Application (2017-2022) & (US$ Million)
Table 35. North America Glutethimide Market Size by Application (2023-2028) & (US$ Million)
Table 36. North America Glutethimide Market Size by Country (2017-2022) & (US$ Million)
Table 37. North America Glutethimide Market Size by Country (2023-2028) & (US$ Million)
Table 38. Europe Glutethimide Market Size by Type (2017-2022) & (US$ Million)
Table 39. Europe Glutethimide Market Size by Type (2023-2028) & (US$ Million)
Table 40. Europe Glutethimide Market Size by Application (2017-2022) & (US$ Million)
Table 41. Europe Glutethimide Market Size by Application (2023-2028) & (US$ Million)
Table 42. Europe Glutethimide Market Size by Country (2017-2022) & (US$ Million)
Table 43. Europe Glutethimide Market Size by Country (2023-2028) & (US$ Million)
Table 44. Asia Pacific Glutethimide Market Size by Type (2017-2022) & (US$ Million)
Table 45. Asia Pacific Glutethimide Market Size by Type (2023-2028) & (US$ Million)
Table 46. Asia Pacific Glutethimide Market Size by Application (2017-2022) & (US$ Million)
Table 47. Asia Pacific Glutethimide Market Size by Application (2023-2028) & (US$ Million)
Table 48. Asia Pacific Glutethimide Market Size by Region (2017-2022) & (US$ Million)
Table 49. Asia Pacific Glutethimide Market Size by Region (2023-2028) & (US$ Million)
Table 50. Latin America Glutethimide Market Size by Type (2017-2022) & (US$ Million)
Table 51. Latin America Glutethimide Market Size by Type (2023-2028) & (US$ Million)
Table 52. Latin America Glutethimide Market Size by Application (2017-2022) & (US$ Million)
Table 53. Latin America Glutethimide Market Size by Application (2023-2028) & (US$ Million)
Table 54. Latin America Glutethimide Market Size by Country (2017-2022) & (US$ Million)
Table 55. Latin America Glutethimide Market Size by Country (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Glutethimide Market Size by Type (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Glutethimide Market Size by Type (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Glutethimide Market Size by Application (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Glutethimide Market Size by Application (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Glutethimide Market Size by Country (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Glutethimide Market Size by Country (2023-2028) & (US$ Million)
Table 62. Pfizer Company Details
Table 63. Pfizer Business Overview
Table 64. Pfizer Glutethimide Product
Table 65. Pfizer Revenue in Glutethimide Business (2017-2022) & (US$ Million)
Table 66. Pfizer Recent Developments
Table 67. Abbott Laboratories Company Details
Table 68. Abbott Laboratories Business Overview
Table 69. Abbott Laboratories Glutethimide Product
Table 70. Abbott Laboratories Revenue in Glutethimide Business (2017-2022) & (US$ Million)
Table 71. Abbott Laboratories Recent Developments
Table 72. Mankind Pharma Company Details
Table 73. Mankind Pharma Business Overview
Table 74. Mankind Pharma Glutethimide Product
Table 75. Mankind Pharma Revenue in Glutethimide Business (2017-2022) & (US$ Million)
Table 76. Mankind Pharma Recent Developments
Table 77. Glaxosimithkine Company Details
Table 78. Glaxosimithkine Business Overview
Table 79. Glaxosimithkine Glutethimide Product
Table 80. Glaxosimithkine Revenue in Glutethimide Business (2017-2022) & (US$ Million)
Table 81. Glaxosimithkine Recent Developments
Table 82. Sanofi Company Details
Table 83. Sanofi Business Overview
Table 84. Sanofi Glutethimide Product
Table 85. Sanofi Revenue in Glutethimide Business (2017-2022) & (US$ Million)
Table 86. Sanofi Recent Developments
Table 87. Novartis Company Details
Table 88. Novartis Business Overview
Table 89. Novartis Glutethimide Product
Table 90. Novartis Revenue in Glutethimide Business (2017-2022) & (US$ Million)
Table 91. Novartis Recent Developments
Table 92. Abbvie Company Details
Table 93. Abbvie Business Overview
Table 94. Abbvie Glutethimide Product
Table 95. Abbvie Revenue in Glutethimide Business (2017-2022) & (US$ Million)
Table 96. Abbvie Recent Developments
Table 97. Bristol Mayers Squibb Company Details
Table 98. Bristol Mayers Squibb Business Overview
Table 99. Bristol Mayers Squibb Glutethimide Product
Table 100. Bristol Mayers Squibb Revenue in Glutethimide Business (2017-2022) & (US$ Million)
Table 101. Bristol Mayers Squibb Recent Developments
Table 102. Astrazeneca Company Details
Table 103. Astrazeneca Business Overview
Table 104. Astrazeneca Glutethimide Product
Table 105. Astrazeneca Revenue in Glutethimide Business (2017-2022) & (US$ Million)
Table 106. Astrazeneca Recent Developments
Table 107. Agilent Technologies Company Details
Table 108. Agilent Technologies Business Overview
Table 109. Agilent Technologies Glutethimide Product
Table 110. Agilent Technologies Revenue in Glutethimide Business (2017-2022) & (US$ Million)
Table 111. Agilent Technologies Recent Developments
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Glutethimide Market Share by Type: 2021 VS 2028
Figure 2. Tablets Features
Figure 3. Injection Features
Figure 4. Capsules Features
Figure 5. Global Glutethimide Market Share by Application: 2021 VS 2028
Figure 6. Hospital Pharmacy Case Studies
Figure 7. Retail Pharmacy Case Studies
Figure 8. Online Pharmacy Case Studies
Figure 9. Glutethimide Report Years Considered
Figure 10. Global Glutethimide Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 11. Global Glutethimide Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Glutethimide Market Share by Region: 2021 VS 2028
Figure 13. Global Glutethimide Market Share by Players in 2021
Figure 14. Global Top Glutethimide Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Glutethimide as of 2021)
Figure 15. The Top 10 and 5 Players Market Share by Glutethimide Revenue in 2021
Figure 16. North America Glutethimide Market Size YoY (2017-2028) & (US$ Million)
Figure 17. North America Glutethimide Market Size Market Share by Type (2017-2028)
Figure 18. North America Glutethimide Market Size Market Share by Application (2017-2028)
Figure 19. North America Glutethimide Market Size Share by Country (2017-2028)
Figure 20. United States Glutethimide Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Canada Glutethimide Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Glutethimide Market Size YoY (2017-2028) & (US$ Million)
Figure 23. Europe Glutethimide Market Size Market Share by Type (2017-2028)
Figure 24. Europe Glutethimide Market Size Market Share by Application (2017-2028)
Figure 25. Europe Glutethimide Market Size Share by Country (2017-2028)
Figure 26. Germany Glutethimide Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. France Glutethimide Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. U.K. Glutethimide Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Italy Glutethimide Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Russia Glutethimide Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Nordic Countries Glutethimide Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Asia-Pacific Glutethimide Market Size YoY (2017-2028) & (US$ Million)
Figure 33. Asia Pacific Glutethimide Market Size Market Share by Type (2017-2028)
Figure 34. Asia Pacific Glutethimide Market Size Market Share by Application (2017-2028)
Figure 35. Asia Pacific Glutethimide Market Size Share by Region (2017-2028)
Figure 36. China Glutethimide Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Japan Glutethimide Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. South Korea Glutethimide Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Southeast Asia Glutethimide Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. India Glutethimide Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Australia Glutethimide Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 42. Latin America Glutethimide Market Size YoY (2017-2028) & (US$ Million)
Figure 43. Latin America Glutethimide Market Size Market Share by Type (2017-2028)
Figure 44. Latin America Glutethimide Market Size Market Share by Application (2017-2028)
Figure 45. Latin America Glutethimide Market Size Share by Country (2017-2028)
Figure 46. Mexico Glutethimide Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Brazil Glutethimide Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Middle East & Africa Glutethimide Market Size YoY (2017-2028) & (US$ Million)
Figure 49. Middle East and Africa Glutethimide Market Size Market Share by Type (2017-2028)
Figure 50. Middle East and Africa Glutethimide Market Size Market Share by Application (2017-2028)
Figure 51. Middle East and Africa Glutethimide Market Size Share by Country (2017-2028)
Figure 52. Turkey Glutethimide Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Saudi Arabia Glutethimide Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. UAE Glutethimide Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Pfizer Revenue Growth Rate in Glutethimide Business (2017-2022)
Figure 56. Abbott Laboratories Revenue Growth Rate in Glutethimide Business (2017-2022)
Figure 57. Mankind Pharma Revenue Growth Rate in Glutethimide Business (2017-2022)
Figure 58. Glaxosimithkine Revenue Growth Rate in Glutethimide Business (2017-2022)
Figure 59. Sanofi Revenue Growth Rate in Glutethimide Business (2017-2022)
Figure 60. Novartis Revenue Growth Rate in Glutethimide Business (2017-2022)
Figure 61. Abbvie Revenue Growth Rate in Glutethimide Business (2017-2022)
Figure 62. Bristol Mayers Squibb Revenue Growth Rate in Glutethimide Business (2017-2022)
Figure 63. Astrazeneca Revenue Growth Rate in Glutethimide Business (2017-2022)
Figure 64. Agilent Technologies Revenue Growth Rate in Glutethimide Business (2017-2022)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

以下、関連資料のご紹介

アレルギー免疫療法のグローバル市場インサイト・予測（～2028年）

Global Allergy Immunotherapies Market Insights and Forecast to 2028
QY2203B01542 2022年3月11日 71Pages
新型コロナウイルス感染症のパンデミックにより、世界のアレルギー免疫療法の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にアレルギー免疫療法...

ドルザグリアチンのグローバル市場インサイト・予測（～2028年）

Global Dorzagliatin Market Insights, Forecast to 2028
MRC2Q12-18998 2022年12月 75Pages
コロナ禍により、ドルザグリアチンの世界市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にドルザグリアチンのグローバル市場のxxx％を占める「...

マルチプレックス免疫蛍光測定法のグローバル市場インサイト・予測（～2028年）

Global Multiplex Immunofluorescence Assay Market Insights and Forecast to 2028
QY2203B06475 2022年3月25日 79Pages
新型コロナウイルス感染症のパンデミックにより、世界のマルチプレックス免疫蛍光測定法の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にマルチ...

タンパク質検出定量化のグローバル市場インサイト・予測（～2028年）

Global Protein Detection Quantification Market Insights, Forecast to 2028
MRC2Q12-18181 2022年12月 92Pages
コロナ禍により、タンパク質検出定量化の世界市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にタンパク質検出定量化のグローバル市場のxxx％を...

代謝遺伝子検査のグローバル市場インサイト・予測（～2028年）

Global Metabolic Genetic Testing Market Insights, Forecast to 2028
MRC2Q12-17891 2022年12月 90Pages
コロナ禍により、代謝遺伝子検査の世界市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に代謝遺伝子検査のグローバル市場のxxx％を占める「次世...